What Researchers Did
Researchers critically reviewed existing and novel pro-angiogenic mediators involved in the healing of diabetic foot ulcers.
What They Found
The review highlighted that diabetic foot ulcers (DFUs) are a significant problem, with lower extremity amputation rates ranging from 3.34% to 42.83%. Current pro-angiogenic therapies, including vascular endothelial growth factor (VEGF), have not yielded satisfactory results, indicating a need for novel mediators to improve angiogenesis and healing.
Canadian Relevance
While published in a Canadian journal, this review does not present specific Canadian data or direct Canadian relevance.
Study Limitations
As a review, this study's findings are dependent on the scope and quality of the existing literature it synthesized.